Morgan Stanley’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Morgan Stanley’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-207,755	Closed	-$23.1K	–	7933
2022 Q4	$23.1K	Sell	207,755 -4,399	-2%	-$2.81K	﹤0.01%	6627
2022 Q3	$225K	Buy	212,154 +197,022	+1,302%	+$449K	﹤0.01%	5680
2022 Q2	$28K	Buy	15,132 +1,771	+13%	+$4.3K	﹤0.01%	6862
2022 Q1	$48K	Buy	13,361 +803	+6%	+$3.94K	﹤0.01%	6729
2021 Q4	$109K	Sell	12,558 -1,415	-10%	-$9K	﹤0.01%	6391
2021 Q3	$105K	Buy	13,973 +1,925	+16%	+$16.2K	﹤0.01%	6345
2021 Q2	$80K	Buy	12,048 +6,901	+134%	+$43.5K	﹤0.01%	6451
2021 Q1	$62K	Buy	+5,147	New	+$102K	﹤0.01%	6257

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Morgan Stanley's LHDX Position: Q1 2023 in Review

Morgan Stanley sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 207,755 shares — an estimated $23.1K sold.

Morgan Stanley first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $225K in Q3 2022. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Morgan Stanley reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 207,755 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $23.1K.
Morgan Stanley first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Morgan Stanley's Lucira Health, Inc. Common Stock position peaked at $225K in Q3 2022.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.